Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Laxative Abuse

para>Children may be given excess laxatives by caregivers (M â ╝nchausen syndrome by proxy). é á
Geriatric Considerations

Elderly in nursing homes are at increased risk for laxative overuse (usually inadvertent).

é á

ETIOLOGY AND PATHOPHYSIOLOGY


  • Four types of chronic diarrhea: secretory, osmotic, inflammatory, and fatty. Rule out other causes, laxative abuse is a diagnosis of exclusion (1).
  • Chronic ingestion of any laxative agent
    • Stimulant (most common, rapid onset of action)
      • Diphenylmethane (Bisacodyl)
      • Anthraquinones (Senna, Cascara, Castor oil)
    • Saline and osmotic products (sodium phosphate, magnesium sulfate/citrate and hydroxide, lactulose, polyethylene glycol)
    • Bulking agents (psyllium)
    • Surfactants (docusate)
  • Psychologic factors
    • Bulimia or anorexia nervosa (associated with behavioral pathology)
    • Secondary gain (attention-seeking): disability claims or need for concern, caring from others
    • Inappropriate perceptions of "normal " Ł bowel habits

RISK FACTORS


In patients with eating disorders é á
  • Longer duration of illness
  • Comorbid psychiatric diagnoses (e.g., major depression, obsessive-compulsive disorder, posttraumatic stress disorder, anxiety, borderline personality disorder)
  • Early age of eating disorder symptoms

GENERAL PREVENTION


  • Educate patients about proper nutrition, normal bowel function, potential adverse effects of excessive laxative use, and medications (e.g., magnesium-containing antacids) that can cause diarrhea.
  • Ask patients specifically about laxative use; inadvertent overuse is common.

COMMONLY ASSOCIATED CONDITIONS


  • Anorexia nervosa, bulimia nervosa
  • Use of constipating medications (opioids, iron supplements).
  • Any chronic disorder associated with constipation
  • Depression and anxiety
  • Borderline personality
  • Self-injurious behaviors/suicidal ideation
  • Impulsive behavior
  • M â ╝nchausen syndrome/M â ╝nchausen syndrome by proxy (children) may have associated factitious symptoms involving diverse organ systems.
  • Fictitious disorders
  • Patient is dependent on a caregiver.

DIAGNOSIS


HISTORY


  • Suspect in patients with undiagnosed, refractory chronic diarrhea.
  • Assess over-the-counter medication use, and take thorough dietary history (2).
  • Signs and symptoms: increasing frequency of bowel movements; large volume, watery diarrhea; nocturnal bowel movements (typically absent in osmotic diarrhea or in irritable bowel syndrome) (2,3).
  • Additional symptoms: abdominal pain, rectal pain, nausea, vomiting, weight loss, malaise, muscle weakness, or chronic constipation.
  • Assess "doctor shopping " Ł and potential factitious symptoms.

PHYSICAL EXAM


  • No specific findings but may include cachexia, evidence of dehydration, abdominal pain or distension, and edema; fever may be due to self-infected wounds or thermometer manipulation (2).
  • Bulimics or anorexics who purge may have Russell sign (excoriation of fingers from repeated self-induced retching) (4); clubbing, cyclic edema, skin pigmentation changes, parotid hypertrophy.
  • Rarely, severe cases may be associated with renal failure, cardiac arrhythmias, skeletal muscle paralysis, anemia from blood-letting or self-induced skin wounds.

DIFFERENTIAL DIAGNOSIS


Any etiology of chronic diarrhea, especially in high-risk groups é á

DIAGNOSTIC TESTS & INTERPRETATION


If patient has not had an initial workup for chronic diarrhea, rule out infectious, inflammatory, and malignant causes based on patient demographics and risk factors. é á
Initial Tests (lab, imaging)
  • Serum electrolytes hypokalemia, hypernatremia, hyperphosphatemia
    • Acute diarrhea: metabolic acidosis (hypovolemia)
    • Chronic diarrhea: metabolic alkalosis secondary to hypokalemia-induced inhibition of chloride uptake with inhibited bicarbonate secretion
  • CBC, stool cultures, Clostridium difficile polymerase chain reaction (PCR) to rule out infectious cause if history is suspicious (fecal leukocytes, ova and parasites (O&P) " öcheck for giardia, isospora, and cryptosporidia specificially) (2,3).
  • Colonoscopy, small-bowel endoscopy, or imaging studies are not usually necessary but help to evaluate other causes of chronic diarrhea (2).
  • Melanosis coli on sigmoidoscopy or colonoscopy indicate overuse of anthracene laxatives.

Follow-Up Tests & Special Considerations
The following algorithm can be used to confirm diagnosis and determine what laxative is being used (1,5)[B]. é á
  • Collect 24-hour stool: If stool is solid, workup is over.
  • Obtain stool osmolality, stool electrolytes, and calculate osmolal gap [ ó ł ĺ 290 ó ł ĺ2(Na+ + K+), Na+ and K+ are stool concentrations.
    • If osmolality >400 mOsm/kg, rule out urine contamination of stool. Measure urea and creatinine of sample.
    • If osmolality <250 to 400 mOsm/kg, rule out water added to stool (colon cannot dilute stool to osmolality of plasma).
    • If osmolality = 250 to 400 mOsm/kg, measure osmolal gap.
      • Gap >50: unmeasured solute; check fecal fat and stool magnesium levels.
      • Gap <50: Rule out use of secretory laxative; urinalysis and stool analysis for laxative titers. Do not obtain serum laxative titers, as they peak 1 to 2 hours after ingestion. Urine titers can be 10 times as high as plasma titers.
  • Confirm diagnosis with multiple stool analyses before addressing patient with concern for intentional abuse.

TREATMENT


GENERAL MEASURES


  • Behavioral support is essential in intentional use.
  • Wean patient off laxatives and supplements; substitute high-fiber diet and bulk preparations or short-term saline enemas
  • Treat secondary constipation (3)[C].
  • Treat metabolic abnormalities.

MEDICATION


Replace needed fluid, vitamins, electrolytes, and minerals. é á
First Line
  • Patient education on normal bowel habits
  • Nonstimulant laxatives (if needed) to treat constipation (3)[C]
    • Polyethylene glycol (3)[C]
    • Lactulose (3)[C]
    • High-fiber diet
  • Precautions: Patients may be manipulative to deny problem; may hide laxatives in hospital rooms.
  • Significant possible interactions
    • Increased rate of intestinal motility may affect rate of absorption of medications (e.g., antibiotics, hormones).
    • Docusate sodium may potentiate hepatotoxicity of other drugs.
    • Consider loperamide to improve anal tone and promote rectal inhibitory reflex (6)[C].

ISSUES FOR REFERRAL


In cases of M â ╝nchausen syndrome by proxy, legal proceedings must be considered, because most victims are children. Behavioral health support for patients with significant psychological comorbidities é á

SURGERY/OTHER PROCEDURES


Avoid exploratory surgery and repetitive evaluations or invasive procedures. é á

INPATIENT CONSIDERATIONS


Admission Criteria/Initial Stabilization
  • Persistent diarrhea with hemodynamic instability
  • Electrolyte/metabolic complications, including lactic acidosis
  • Cardiac arrhythmias

IV Fluids
Resuscitate based on clinical presentation. If patient is hemodynamically stable and without significant abnormalities in serum sodium, give normal saline boluses or oral replacement to correct metabolic alkalosis (chronic) or acidosis (acute) as needed. If patient is hemodynamically unstable, treat volume status as in hypovolemic shock, while monitoring serum electrolytes closely (especially sodium, potassium, and bicarbonate (6,7)[C]. é á
Nursing
If stable, patient does not need continuous telemetry. Depending on psychiatric history, patient may need one-on-one or line-of-sight observation. Special care must be taken to ensure adequate nutrition and control access to laxatives. If surreptitious laxative ingestion is suspected, do not perform unauthorized room searches due to legal constraints. é á
Discharge Criteria
  • Psychological evaluation, support, and follow-up
  • Diet and bowel programs
  • Resolution of electrolyte abnormalities/dehydration

ONGOING CARE


FOLLOW-UP RECOMMENDATIONS


Patient Monitoring
  • Ongoing behavioral counseling
  • Careful medical support; frequent visits as needed
  • Assess serum electrolytes.

DIET


Ensure good nutritional habits. é á
  • Increase fiber intake.
  • Avoid constipating substances.
  • Adequate calories, especially with bulimia

PROGNOSIS


  • Natural history is unclear and varied depending on underlying cause.
  • Prognosis is related to underlying behavioral disorders in intentional abuse or underlying organic disease (if present).
  • Prognosis is poor with anorexia nervosa; very poor in M â ╝nchausen syndrome.
  • Cathartic colon is commonly refractory to treatment (7)[C].

COMPLICATIONS


  • Risk of multiple tests, procedures, and surgeries (intentional use)
  • Malnutrition
  • Electrolyte imbalances (hypokalemia, hypermagnesemia, phosphate nephropathy) (3)
  • Renal failure
  • Cardiac arrhythmias/sudden death (3)
  • Renal calculi
  • Cathartic colon with constipation as a consequence of prolonged irritant laxative use (7)
  • Fecal impaction in elderly
  • Recurrences are common for factitious abuse, even after confrontation.
  • Rebound edema (7)

REFERENCES


11 Thomas é áPD, Forbes é áA, Green é áJ, et al. Guidelines for the investigation of chronic diarrhoea, 2nd edition. Gut.  2003;52(Suppl 5):v1 " ôv15.22 Schiller é áLR. Definitions, pathophysiology, and evaluation of chronic diarrhoea. Best Pract Res Clin Gastroenterol.  2012;26(5):551 " ô562.33 Roerig é áJL, Steffen é áKJ, Mitchell é áJE, et al. Laxative abuse: epidemiology, diagnosis and management. Drugs.  2010;70(12):1487 " ô1503.44 Sim é áLA, McAlpine é áDE, Grothe é áKB, et al. Identification and treatment of eating disorders in the primary care setting. Mayo Clin Proc.  2010;85(8):746 " ô751.55 Fine é áKD, Santa Ana é áCA, Fordtran é áJS. Diagnosis of magnesium-induced diarrhea. N Engl J Med.  1991;324(15):1012 " ô1017.66 Kent é áAJ, Banks é áMR. Pharmacologic management of diarrhea. Gastroenterol Clin North Am.  2010;39(3):495 " ô507.77 Neims é áDM, McNeill é áJ, Giles é áTR, et al. Incidence of laxative abuse in community and bulimic populations: a descriptive review. Int J Eat Disord.  1995;17(3):211 " ô228.

ADDITIONAL READING


  • Abraham é áBP, Sellin é áJH. Drug-induced, factitious, and idiopathic diarrhea. Best Pract Res Clin Gastroenterol.  2012;26(5):633 " ô648.
  • Bytzer é áP, Stokholm é áM, Andersen é áI, et al. Prevalence of surreptitious laxative abuse in patients with diarrhoea of uncertain origin: a cost benefit analysis of a screening procedure. Gut.  1989;30(10):1379 " ô1384.
  • Shelton é áJH, Santa Ana é áCA, Thompson é áDR, et al. Factitious diarrhea induced by stimulant laxatives: accuracy of diagnosis by a clinical reference laboratory using thin layer chromatography. Clin Chem.  2007;53(1):85 " ô90.
  • Sweetser é áS. Evaluating the patient with diarrhea: a case-based approach. Mayo Clin Proc.  2012;87(6):596 " ô602.
  • Tozzi é áF, Thornton é áLM, Mitchell é áJ, et al. Features associated with laxative abuse in individulals with eating disorders. Psychosom Med.  2006;68(3):470 " ô477.

SEE ALSO


Algorithm: Diarrhea, Chronic é á

CODES


ICD10


F55.2 Abuse of laxatives é á

ICD9


305.90 Other, mixed, or unspecified drug abuse, unspecified é á

SNOMED


  • 280982009 Abuse of laxatives (disorder)
  • 27051000119102 Chronic abuse of laxatives (disorder)
  • 236074001 diarrhea due to laxative abuse (disorder)

CLINICAL PEARLS


  • Laxative abuse may be intentional or unintentional.
  • When associated with eating disorders, laxative abuse is associated with more severe disease.
  • Consider laxative abuse in patients with watery diarrhea, especially if unexplained or refractory.
  • As many as 15% of patients referred to tertiary care centers for unexplained chronic diarrhea abuse laxatives.
  • Presentation is diverse and nonspecific including weight loss, weakness, and hypotension.
  • Patients often won 't acknowledge diarrhea if laxative abuse is intentional.
Copyright © 2016 - 2017
Doctor123.org | Disclaimer